{"id": "IEPA.d2.s2_IEPA.d2.s2.p2", "text": "SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16", "text_with_entity_marker": "SP ewes also had greater incorporation of [3H]inositol into [E1]inositol trisphosphate[/E1] (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for [E2]IP3[/E2] and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "inositol trisphosphate", "entity_1_idx": [[60, 82]], "entity_1_idx_in_text_with_entity_marker": [64, 86], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[241, 244]], "entity_2_idx_in_text_with_entity_marker": [254, 257], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d2.s2_IEPA.d2.s2.p7", "text": "SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16", "text_with_entity_marker": "SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to [E1]oxytocin[/E1], than did oCSP ewes (+553 and +168% for [E2]IP3[/E2] and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[192, 200]], "entity_1_idx_in_text_with_entity_marker": [196, 204], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[241, 244]], "entity_2_idx_in_text_with_entity_marker": [254, 257], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d14.s31_IEPA.d14.s31.p0", "text": "This indicates that the calcium response to OT application was principally associated with activation of the IP3-sensitive calcium stores", "text_with_entity_marker": "This indicates that the calcium response to [E1]OT[/E1] application was principally associated with activation of the [E2]IP3[/E2]-sensitive calcium stores", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "OT", "entity_1_idx": [[44, 46]], "entity_1_idx_in_text_with_entity_marker": [48, 50], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[109, 112]], "entity_2_idx_in_text_with_entity_marker": [122, 125], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d17.s35_IEPA.d17.s35.p0", "text": "The highest production of total inositol phosphates (d.p.m.) was found in cells from ovariectomized gilts given in vivo estradiol benzoate and progesterone for five consecutive days and treated with 1000 mU hCG and 100 mU hCG plus 1 microM oxytocin (984 +/- 84 and 1063 +/- 131 vs 314 +/- 36, respectively)", "text_with_entity_marker": "The highest production of total [E1]inositol phosphates[/E1] (d.p.m.) was found in cells from ovariectomized gilts given in vivo estradiol benzoate and progesterone for five consecutive days and treated with 1000 mU hCG and 100 mU hCG plus 1 microM [E2]oxytocin[/E2] (984 +/- 84 and 1063 +/- 131 vs 314 +/- 36, respectively)", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "inositol phosphates", "entity_1_idx": [[32, 51]], "entity_1_idx_in_text_with_entity_marker": [36, 55], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[240, 248]], "entity_2_idx_in_text_with_entity_marker": [253, 261], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d17.s36_IEPA.d17.s36.p1", "text": "There was also a very significant increase of IP1 after the addition of 1000 mU hCG (p < 0.001) and IP1 and IP3 when 1000 mU hCG plus oxytocin were added (p < 0.001 and p < 0.01, respectively)", "text_with_entity_marker": "There was also a very significant increase of [E1]IP1[/E1] after the addition of 1000 mU hCG (p < 0.001) and IP1 and [E2]IP3[/E2] when 1000 mU hCG plus oxytocin were added (p < 0.001 and p < 0.01, respectively)", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IP1", "entity_1_idx": [[46, 49]], "entity_1_idx_in_text_with_entity_marker": [50, 53], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[108, 111]], "entity_2_idx_in_text_with_entity_marker": [121, 124], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d17.s36_IEPA.d17.s36.p4", "text": "There was also a very significant increase of IP1 after the addition of 1000 mU hCG (p < 0.001) and IP1 and IP3 when 1000 mU hCG plus oxytocin were added (p < 0.001 and p < 0.01, respectively)", "text_with_entity_marker": "There was also a very significant increase of IP1 after the addition of 1000 mU hCG (p < 0.001) and [E1]IP1[/E1] and IP3 when 1000 mU hCG plus [E2]oxytocin[/E2] were added (p < 0.001 and p < 0.01, respectively)", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "IP1", "entity_1_idx": [[100, 103]], "entity_1_idx_in_text_with_entity_marker": [104, 107], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[134, 142]], "entity_2_idx_in_text_with_entity_marker": [147, 155], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d17.s36_IEPA.d17.s36.p5", "text": "There was also a very significant increase of IP1 after the addition of 1000 mU hCG (p < 0.001) and IP1 and IP3 when 1000 mU hCG plus oxytocin were added (p < 0.001 and p < 0.01, respectively)", "text_with_entity_marker": "There was also a very significant increase of IP1 after the addition of 1000 mU hCG (p < 0.001) and IP1 and [E1]IP3[/E1] when 1000 mU hCG plus [E2]oxytocin[/E2] were added (p < 0.001 and p < 0.01, respectively)", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "IP3", "entity_1_idx": [[108, 111]], "entity_1_idx_in_text_with_entity_marker": [112, 115], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[134, 142]], "entity_2_idx_in_text_with_entity_marker": [147, 155], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d24.s48_IEPA.d24.s48.p0", "text": "The aim of the present study was to investigate how oxytocin given subcutaneously (SC) and intracerebroventricularly (ICV) influences the secretion of insulin, glucagon and glucose and to investigate whether the effect on these variables of suckling in lactating rats is mediated by oxytocinergic mechanisms", "text_with_entity_marker": "The aim of the present study was to investigate how [E1]oxytocin[/E1] given subcutaneously (SC) and intracerebroventricularly (ICV) influences the secretion of [E2]insulin[/E2], glucagon and glucose and to investigate whether the effect on these variables of suckling in lactating rats is mediated by oxytocinergic mechanisms", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[52, 60]], "entity_1_idx_in_text_with_entity_marker": [56, 64], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[151, 158]], "entity_2_idx_in_text_with_entity_marker": [164, 171], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d24.s51_IEPA.d24.s51.p0", "text": "The oxytocin antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased insulin levels itself and therefore the effect on oxytocin-induced insulin secretion was difficult to evaluate", "text_with_entity_marker": "The [E1]oxytocin[/E1] antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased [E2]insulin[/E2] levels itself and therefore the effect on oxytocin-induced insulin secretion was difficult to evaluate", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[4, 12]], "entity_1_idx_in_text_with_entity_marker": [8, 16], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[96, 103]], "entity_2_idx_in_text_with_entity_marker": [109, 116], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d26.s56_IEPA.d26.s56.p0", "text": "The SGR and RGR also had different endocrine profiles with, for example, twice as high oxytocin (p < 0.01) and insulin levels (p < 0.01) in RGR compared to the SGR", "text_with_entity_marker": "The SGR and RGR also had different endocrine profiles with, for example, twice as high [E1]oxytocin[/E1] (p < 0.01) and [E2]insulin[/E2] levels (p < 0.01) in RGR compared to the SGR", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[87, 95]], "entity_1_idx_in_text_with_entity_marker": [91, 99], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[111, 118]], "entity_2_idx_in_text_with_entity_marker": [124, 131], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d31.s63_IEPA.d31.s63.p0", "text": "OT may rapidly stimulate inositol (1,4,5)-trisphosphate (IP3) and diacylglycerol (DAG) formation, consistent with the concept of rapid activation of a second-messenger system", "text_with_entity_marker": "[E1]OT[/E1] may rapidly stimulate [E2]inositol (1,4,5)-trisphosphate[/E2] (IP3) and diacylglycerol (DAG) formation, consistent with the concept of rapid activation of a second-messenger system", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "OT", "entity_1_idx": [[0, 2]], "entity_1_idx_in_text_with_entity_marker": [4, 6], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "inositol (1,4,5)-trisphosphate", "entity_2_idx": [[25, 55]], "entity_2_idx_in_text_with_entity_marker": [38, 68], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d31.s64_IEPA.d31.s64.p0", "text": "In support of this hypothesis, endometrial IP3 levels were increased (P < 0.05) within 0.5 min after treatment with 0.1 microM OT", "text_with_entity_marker": "In support of this hypothesis, endometrial [E1]IP3[/E1] levels were increased (P < 0.05) within 0.5 min after treatment with 0.1 microM [E2]OT[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "IP3", "entity_1_idx": [[43, 46]], "entity_1_idx_in_text_with_entity_marker": [47, 50], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "OT", "entity_2_idx": [[127, 129]], "entity_2_idx_in_text_with_entity_marker": [140, 142], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d32.s70_IEPA.d32.s70.p0", "text": "These data indicate a GABAergic mediation of the inhibitory modulation by NO of the AVP and OT responses to insulin-induced hypoglycemia", "text_with_entity_marker": "These data indicate a GABAergic mediation of the inhibitory modulation by NO of the AVP and [E1]OT[/E1] responses to [E2]insulin[/E2]-induced hypoglycemia", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "OT", "entity_1_idx": [[92, 94]], "entity_1_idx_in_text_with_entity_marker": [96, 98], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[108, 115]], "entity_2_idx_in_text_with_entity_marker": [121, 128], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d33.s75_IEPA.d33.s75.p0", "text": "On Day 28 of pregnancy, OT receptors became detectable, and then OT could induce the formation of IPs", "text_with_entity_marker": "On Day 28 of pregnancy, OT receptors became detectable, and then [E1]OT[/E1] could induce the formation of [E2]IPs[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "OT", "entity_1_idx": [[65, 67]], "entity_1_idx_in_text_with_entity_marker": [69, 71], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IPs", "entity_2_idx": [[98, 101]], "entity_2_idx_in_text_with_entity_marker": [111, 114], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d35.s86_IEPA.d35.s86.p2", "text": "Oxytocin (OT) and vasopressin (AVP) stimulate insulin and glucagon release from the pancreas, and evoke insulin secretion from the rat insulinoma cell line, RINm5F", "text_with_entity_marker": "Oxytocin (OT) and vasopressin (AVP) stimulate [E1]insulin[/E1] and glucagon release from the pancreas, and evoke [E2]insulin[/E2] secretion from the rat insulinoma cell line, RINm5F", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[46, 53]], "entity_1_idx_in_text_with_entity_marker": [50, 57], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[104, 111]], "entity_2_idx_in_text_with_entity_marker": [117, 124], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d36.s87_IEPA.d36.s87.p0", "text": "Wortmannin converts insulin but not oxytocin from an antilipolytic to a lipolytic agent in the presence of forskolin", "text_with_entity_marker": "Wortmannin converts [E1]insulin[/E1] but not [E2]oxytocin[/E2] from an antilipolytic to a lipolytic agent in the presence of forskolin", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[20, 27]], "entity_1_idx_in_text_with_entity_marker": [24, 31], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[36, 44]], "entity_2_idx_in_text_with_entity_marker": [49, 57], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d42.s107_IEPA.d42.s107.p0", "text": "When taken in their entirety, the experimental evidence suggests that the activation of PLC is an essential component in the physiologic regulation of insulin secretion and that disordered activation of the enzyme culminates in disordered insulin release", "text_with_entity_marker": "When taken in their entirety, the experimental evidence suggests that the activation of [E1]PLC[/E1] is an essential component in the physiologic regulation of [E2]insulin[/E2] secretion and that disordered activation of the enzyme culminates in disordered insulin release", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PLC", "entity_1_idx": [[88, 91]], "entity_1_idx_in_text_with_entity_marker": [92, 95], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[151, 158]], "entity_2_idx_in_text_with_entity_marker": [164, 171], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d46.s119_IEPA.d46.s119.p0", "text": "It is suggested that this observed amyloid beta protein stimulation of phospholipase C may be responsible for the elevated quantity of inositol seen in the brains of Alzheimer's disease patients", "text_with_entity_marker": "It is suggested that this observed [E1]amyloid[/E1] beta protein stimulation of [E2]phospholipase C[/E2] may be responsible for the elevated quantity of inositol seen in the brains of Alzheimer's disease patients", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "amyloid", "entity_1_idx": [[35, 42]], "entity_1_idx_in_text_with_entity_marker": [39, 46], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[71, 86]], "entity_2_idx_in_text_with_entity_marker": [84, 99], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d50.s127_IEPA.d50.s127.p1", "text": "Insulin secretion is regulated by changes in blood glucose, as well as by peptides from the gastrointestinal tract and neurotransmitters that activate the pancreatic islet adenylyl cyclase (e.g., glucagon-like peptide-1) and phospholipase C (PLC) (e.g., acetylcholine) signaling pathways to further potentiate glucose-induced insulin secretion", "text_with_entity_marker": "[E1]Insulin[/E1] secretion is regulated by changes in blood glucose, as well as by peptides from the gastrointestinal tract and neurotransmitters that activate the pancreatic islet adenylyl cyclase (e.g., glucagon-like peptide-1) and phospholipase C (PLC) (e.g., acetylcholine) signaling pathways to further potentiate glucose-induced [E2]insulin[/E2] secretion", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Insulin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[326, 333]], "entity_2_idx_in_text_with_entity_marker": [339, 346], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d50.s128_IEPA.d50.s128.p0", "text": "However, leptin did constrain the enhanced PLC-mediated insulin secretion characteristic of islets from ob/ob mice, without influencing release from islets of lean mice", "text_with_entity_marker": "However, leptin did constrain the enhanced [E1]PLC[/E1]-mediated [E2]insulin[/E2] secretion characteristic of islets from ob/ob mice, without influencing release from islets of lean mice", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PLC", "entity_1_idx": [[43, 46]], "entity_1_idx_in_text_with_entity_marker": [47, 50], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[56, 63]], "entity_2_idx_in_text_with_entity_marker": [69, 76], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d52.s135_IEPA.d52.s135.p0", "text": "Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and leptin", "text_with_entity_marker": "[E1]Uncoupling protein-3[/E1] is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and [E2]leptin[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Uncoupling protein-3", "entity_1_idx": [[0, 20]], "entity_1_idx_in_text_with_entity_marker": [4, 24], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[113, 119]], "entity_2_idx_in_text_with_entity_marker": [126, 132], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d53.s137_IEPA.d53.s137.p0", "text": "During luteinization of bovine granulosa cells in vitro in the presence of insulin, or insulin plus forskolin, there is a massive upregulation not only of progesterone production, but also of the gene for the peptide hormone oxytocin, with secretion of the peptide into the medium", "text_with_entity_marker": "During luteinization of bovine granulosa cells in vitro in the presence of [E1]insulin[/E1], or [E2]insulin[/E2] plus forskolin, there is a massive upregulation not only of progesterone production, but also of the gene for the peptide hormone oxytocin, with secretion of the peptide into the medium", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[75, 82]], "entity_1_idx_in_text_with_entity_marker": [79, 86], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[87, 94]], "entity_2_idx_in_text_with_entity_marker": [100, 107], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d53.s137_IEPA.d53.s137.p1", "text": "During luteinization of bovine granulosa cells in vitro in the presence of insulin, or insulin plus forskolin, there is a massive upregulation not only of progesterone production, but also of the gene for the peptide hormone oxytocin, with secretion of the peptide into the medium", "text_with_entity_marker": "During luteinization of bovine granulosa cells in vitro in the presence of [E1]insulin[/E1], or insulin plus forskolin, there is a massive upregulation not only of progesterone production, but also of the gene for the peptide hormone [E2]oxytocin[/E2], with secretion of the peptide into the medium", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[75, 82]], "entity_1_idx_in_text_with_entity_marker": [79, 86], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[225, 233]], "entity_2_idx_in_text_with_entity_marker": [238, 246], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d57.s146_IEPA.d57.s146.p0", "text": "Activation of EGFR overexpressing 3T3-L1 adipocytes leads to a 3.4 +/- 1.2-fold stimulation of PLC activity over basal levels vs. only 1.06 +/- 0.01-fold stimulation by insulin.", "text_with_entity_marker": "Activation of EGFR overexpressing 3T3-L1 adipocytes leads to a 3.4 +/- 1.2-fold stimulation of [E1]PLC[/E1] activity over basal levels vs. only 1.06 +/- 0.01-fold stimulation by [E2]insulin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PLC", "entity_1_idx": [[95, 98]], "entity_1_idx_in_text_with_entity_marker": [99, 102], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[169, 176]], "entity_2_idx_in_text_with_entity_marker": [182, 189], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d57.s148_IEPA.d57.s148.p2", "text": "Inhibition of PLC activation did not impair either EGF- or insulin-induced activation of glycogen synthase or incorporation of glucose into lipid, supporting the hypothesis that both EGF- and insulin-induced glucose disposal can be independent of GLUT4-mediated glucose transport.", "text_with_entity_marker": "Inhibition of PLC activation did not impair either EGF- or [E1]insulin[/E1]-induced activation of glycogen synthase or incorporation of glucose into lipid, supporting the hypothesis that both EGF- and [E2]insulin[/E2]-induced glucose disposal can be independent of GLUT4-mediated glucose transport.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[59, 66]], "entity_1_idx_in_text_with_entity_marker": [63, 70], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[192, 199]], "entity_2_idx_in_text_with_entity_marker": [205, 212], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d57.s149_IEPA.d57.s149.p0", "text": "The diminution of glucose transport secondary to inhibition of PLC activity was reflected by a decrease in GLUT4 translocation to the plasma membrane upon either EGF or insulin stimulation", "text_with_entity_marker": "The diminution of glucose transport secondary to inhibition of [E1]PLC[/E1] activity was reflected by a decrease in GLUT4 translocation to the plasma membrane upon either EGF or [E2]insulin[/E2] stimulation", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC", "entity_1_idx": [[63, 66]], "entity_1_idx_in_text_with_entity_marker": [67, 70], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[169, 176]], "entity_2_idx_in_text_with_entity_marker": [182, 189], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d58.s153_IEPA.d58.s153.p3", "text": "We conclude that: (1) AVP causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the AVP-induced increase in MARCKS phosphorylation occurs much earlier in these cells than does PKC trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of PKC activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.", "text_with_entity_marker": "We conclude that: (1) AVP causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the [E1]AVP[/E1]-induced increase in MARCKS phosphorylation occurs much earlier in these cells than does [E2]PKC[/E2] trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of PKC activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AVP", "entity_1_idx": [[143, 146]], "entity_1_idx_in_text_with_entity_marker": [147, 150], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[235, 238]], "entity_2_idx_in_text_with_entity_marker": [248, 251], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d63.s160_IEPA.d63.s160.p0", "text": "However, in brown fat, we observed a 2-3-fold increase in the expression of UCP1 in response to dietary fat challenge, which may be related to diet-induced elevations in plasma leptin levels", "text_with_entity_marker": "However, in brown fat, we observed a 2-3-fold increase in the expression of [E1]UCP1[/E1] in response to dietary fat challenge, which may be related to diet-induced elevations in plasma [E2]leptin[/E2] levels", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UCP1", "entity_1_idx": [[76, 80]], "entity_1_idx_in_text_with_entity_marker": [80, 84], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[177, 183]], "entity_2_idx_in_text_with_entity_marker": [190, 196], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d64.s161_IEPA.d64.s161.p0", "text": "Similarly, carbachol, but not AVP or DDAVP, induced a significant increase in membrane-associated protein kinase C (PKC) enzyme activity", "text_with_entity_marker": "Similarly, carbachol, but not [E1]AVP[/E1] or DDAVP, induced a significant increase in membrane-associated [E2]protein kinase C[/E2] (PKC) enzyme activity", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AVP", "entity_1_idx": [[30, 33]], "entity_1_idx_in_text_with_entity_marker": [34, 37], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[98, 114]], "entity_2_idx_in_text_with_entity_marker": [111, 127], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d72.s173_IEPA.d72.s173.p0", "text": "Treatment with (+)-trifluoro-ABA strongly inhibited the gibberellic acid-inducible expression of alpha-amylase I-1 encoded by RAmy1A in the aleurone layers of embryoless half-seeds at the levels of transcription, protein synthesis, and enzyme activity", "text_with_entity_marker": "Treatment with (+)-trifluoro-ABA strongly inhibited the [E1]gibberellic acid[/E1]-inducible expression of [E2]alpha-amylase[/E2] I-1 encoded by RAmy1A in the aleurone layers of embryoless half-seeds at the levels of transcription, protein synthesis, and enzyme activity", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gibberellic acid", "entity_1_idx": [[56, 72]], "entity_1_idx_in_text_with_entity_marker": [60, 76], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[97, 110]], "entity_2_idx_in_text_with_entity_marker": [110, 123], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d74.s177_IEPA.d74.s177.p4", "text": "In marked contrast, intracerebroventricular leptin administration was accompanied by the maintenance of high UCP1, UCP2, and UCP3 expression in all these tissues", "text_with_entity_marker": "In marked contrast, intracerebroventricular leptin administration was accompanied by the maintenance of high [E1]UCP1[/E1], UCP2, and [E2]UCP3[/E2] expression in all these tissues", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP1", "entity_1_idx": [[109, 113]], "entity_1_idx_in_text_with_entity_marker": [113, 117], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[125, 129]], "entity_2_idx_in_text_with_entity_marker": [138, 142], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d81.s193_IEPA.d81.s193.p0", "text": "It has been established that amyloid beta peptide (AbetaP) activates phospholipase A2, phospholipase C and phospholipase D of LA-N-2 cells and other cell types", "text_with_entity_marker": "It has been established that [E1]amyloid[/E1] beta peptide (AbetaP) activates phospholipase A2, [E2]phospholipase C[/E2] and phospholipase D of LA-N-2 cells and other cell types", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "amyloid", "entity_1_idx": [[29, 36]], "entity_1_idx_in_text_with_entity_marker": [33, 40], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[87, 102]], "entity_2_idx_in_text_with_entity_marker": [100, 115], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d84.s203_IEPA.d84.s203.p0", "text": "CONCLUSIONS: These data indicate that a residual endogenous insulin secretion exerts a partial protective action against the hypothalamic-pituitary disorder affecting the OT secretory system in IDDM", "text_with_entity_marker": "CONCLUSIONS: These data indicate that a residual endogenous [E1]insulin[/E1] secretion exerts a partial protective action against the hypothalamic-pituitary disorder affecting the [E2]OT[/E2] secretory system in IDDM", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[60, 67]], "entity_1_idx_in_text_with_entity_marker": [64, 71], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "OT", "entity_2_idx": [[171, 173]], "entity_2_idx_in_text_with_entity_marker": [184, 186], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s207_IEPA.d88.s207.p0", "text": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "text_with_entity_marker": "To elucidate the pathophysiologic significance of [E1]UCP3[/E1] and [E2]UCP2[/E2] in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP3", "entity_1_idx": [[50, 54]], "entity_1_idx_in_text_with_entity_marker": [54, 58], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[59, 63]], "entity_2_idx_in_text_with_entity_marker": [72, 76], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s207_IEPA.d88.s207.p9", "text": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "text_with_entity_marker": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding [E1]UCP3[/E1] and [E2]UCP2[/E2] in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP3", "entity_1_idx": [[364, 368]], "entity_1_idx_in_text_with_entity_marker": [368, 372], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[373, 377]], "entity_2_idx_in_text_with_entity_marker": [386, 390], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d89.s212_IEPA.d89.s212.p3", "text": "The present study indicates that leptin increases the gene expression of UCP2 in EWAT and that of UCP1, UCP3 and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT", "text_with_entity_marker": "The present study indicates that leptin increases the gene expression of [E1]UCP2[/E1] in EWAT and that of [E2]UCP1[/E2], UCP3 and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP2", "entity_1_idx": [[73, 77]], "entity_1_idx_in_text_with_entity_marker": [77, 81], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP1", "entity_2_idx": [[98, 102]], "entity_2_idx_in_text_with_entity_marker": [111, 115], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d89.s212_IEPA.d89.s212.p5", "text": "The present study indicates that leptin increases the gene expression of UCP2 in EWAT and that of UCP1, UCP3 and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT", "text_with_entity_marker": "The present study indicates that leptin increases the gene expression of UCP2 in EWAT and that of [E1]UCP1[/E1], [E2]UCP3[/E2] and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP1", "entity_1_idx": [[98, 102]], "entity_1_idx_in_text_with_entity_marker": [102, 106], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[104, 108]], "entity_2_idx_in_text_with_entity_marker": [117, 121], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d90.s213_IEPA.d90.s213.p0", "text": "DNase1 footprints suggest the involvement of at least three types of transcription factors in the regulation of alpha-Amy2/A by gibberellin", "text_with_entity_marker": "DNase1 footprints suggest the involvement of at least three types of transcription factors in the regulation of [E1]alpha-Amy2/A[/E1] by [E2]gibberellin[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-Amy2/A", "entity_1_idx": [[112, 124]], "entity_1_idx_in_text_with_entity_marker": [116, 128], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "gibberellin", "entity_2_idx": [[128, 139]], "entity_2_idx_in_text_with_entity_marker": [141, 152], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d99.s238_IEPA.d99.s238.p1", "text": "To study the effects of enhanced phosphoinositide hydrolysis on insulin secretion, phosphoinositide-specific phospholipase Cbeta1 (PLCbeta1) or PLCdelta1 was overexpressed in insulinoma MIN6 cells via adenoviral vectors.", "text_with_entity_marker": "To study the effects of enhanced phosphoinositide hydrolysis on [E1]insulin[/E1] secretion, phosphoinositide-specific phospholipase Cbeta1 (PLCbeta1) or [E2]PLCdelta1[/E2] was overexpressed in insulinoma MIN6 cells via adenoviral vectors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[64, 71]], "entity_1_idx_in_text_with_entity_marker": [68, 75], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLCdelta1", "entity_2_idx": [[144, 153]], "entity_2_idx_in_text_with_entity_marker": [157, 166], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d105.s244_IEPA.d105.s244.p0", "text": "The deduced consensus closely resembled gibberellin response elements in alpha-amylase promoters", "text_with_entity_marker": "The deduced consensus closely resembled [E1]gibberellin[/E1] response elements in [E2]alpha-amylase[/E2] promoters", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gibberellin", "entity_1_idx": [[40, 51]], "entity_1_idx_in_text_with_entity_marker": [44, 55], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[73, 86]], "entity_2_idx_in_text_with_entity_marker": [86, 99], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d107.s248_IEPA.d107.s248.p0", "text": "To understand the molecular mechanism of gibberellin-dependent gene regulation, the effect of three phosphatase inhibitors on the germination of rice seeds and the expression of a target gene, the alpha-amylase gene, Osamy-c, were measured", "text_with_entity_marker": "To understand the molecular mechanism of [E1]gibberellin[/E1]-dependent gene regulation, the effect of three phosphatase inhibitors on the germination of rice seeds and the expression of a target gene, the [E2]alpha-amylase[/E2] gene, Osamy-c, were measured", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gibberellin", "entity_1_idx": [[41, 52]], "entity_1_idx_in_text_with_entity_marker": [45, 56], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[197, 210]], "entity_2_idx_in_text_with_entity_marker": [210, 223], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d108.s252_IEPA.d108.s252.p0", "text": "The present study was designed to investigate how repeated injections of oxytocin influence plasma levels of vagally controlled hormones such as gastrin, cholecystokinin (CCK), insulin and somatostatin, as well as of endogenous oxytocin and glucose", "text_with_entity_marker": "The present study was designed to investigate how repeated injections of [E1]oxytocin[/E1] influence plasma levels of vagally controlled hormones such as gastrin, cholecystokinin (CCK), [E2]insulin[/E2] and somatostatin, as well as of endogenous oxytocin and glucose", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[73, 81]], "entity_1_idx_in_text_with_entity_marker": [77, 85], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[177, 184]], "entity_2_idx_in_text_with_entity_marker": [190, 197], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s260_IEPA.d109.s260.p0", "text": "Fasting also significantly decreased BAT UCP-1 protein expression, to 67% of control; however, that effect was not prevented by leptin treatment", "text_with_entity_marker": "Fasting also significantly decreased BAT [E1]UCP-1[/E1] protein expression, to 67% of control; however, that effect was not prevented by [E2]leptin[/E2] treatment", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP-1", "entity_1_idx": [[41, 46]], "entity_1_idx_in_text_with_entity_marker": [45, 50], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[128, 134]], "entity_2_idx_in_text_with_entity_marker": [141, 147], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d114.s275_IEPA.d114.s275.p1", "text": "To determine whether UCP-2 does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in leptin-unresponsive UCP-2-underexpressing islets of diabetic ZDF rats, we transferred the UCP-2 gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats", "text_with_entity_marker": "To determine whether [E1]UCP-2[/E1] does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in leptin-unresponsive [E2]UCP-2[/E2]-underexpressing islets of diabetic ZDF rats, we transferred the UCP-2 gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP-2", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-2", "entity_2_idx": [[168, 173]], "entity_2_idx_in_text_with_entity_marker": [181, 186], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d117.s285_IEPA.d117.s285.p1", "text": "The second class of mutant, gse (GA sensitivity), differed principally in GA sensitivity, requiring approximately 100-fold higher [GA3] for both leaf elongation and alpha-amylase production by aleurone", "text_with_entity_marker": "The second class of mutant, gse ([E1]GA[/E1] sensitivity), differed principally in GA sensitivity, requiring approximately 100-fold higher [[E2]GA3[/E2]] for both leaf elongation and alpha-amylase production by aleurone", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GA", "entity_1_idx": [[33, 35]], "entity_1_idx_in_text_with_entity_marker": [37, 39], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "GA3", "entity_2_idx": [[131, 134]], "entity_2_idx_in_text_with_entity_marker": [144, 147], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s299_IEPA.d126.s299.p2", "text": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels", "text_with_entity_marker": "The expression of uterine [E1]UCP2[/E1] and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of [E2]leptin[/E2] resulted in induction of the uterine UCP2 and UCP3 levels", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP2", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[208, 214]], "entity_2_idx_in_text_with_entity_marker": [221, 227], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s299_IEPA.d126.s299.p7", "text": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels", "text_with_entity_marker": "The expression of uterine UCP2 and [E1]UCP3[/E1] were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine [E2]UCP2[/E2] and UCP3 levels", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP3", "entity_1_idx": [[35, 39]], "entity_1_idx_in_text_with_entity_marker": [39, 43], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[252, 256]], "entity_2_idx_in_text_with_entity_marker": [265, 269], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s299_IEPA.d126.s299.p12", "text": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels", "text_with_entity_marker": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of [E1]leptin[/E1] resulted in induction of the uterine [E2]UCP2[/E2] and UCP3 levels", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[208, 214]], "entity_1_idx_in_text_with_entity_marker": [212, 218], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[252, 256]], "entity_2_idx_in_text_with_entity_marker": [265, 269], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s300_IEPA.d126.s300.p5", "text": "These results indicate that UCP gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine UCP2 and UCP3 mRNA may be due to increased leptin levels", "text_with_entity_marker": "These results indicate that UCP gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine UCP2 and [E1]UCP3[/E1] mRNA may be due to increased [E2]leptin[/E2] levels", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UCP3", "entity_1_idx": [[138, 142]], "entity_1_idx_in_text_with_entity_marker": [142, 146], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[172, 178]], "entity_2_idx_in_text_with_entity_marker": [185, 191], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d127.s302_IEPA.d127.s302.p2", "text": "When this parental line was treated with PI-PLC, Abeta40, Abeta42, and sAPPbeta decreased to levels similar to those observed in the mutant line, and the mutant line was resistant to these effects of PI-PLC", "text_with_entity_marker": "When this parental line was treated with [E1]PI-PLC[/E1], Abeta40, Abeta42, and sAPPbeta decreased to levels similar to those observed in the mutant line, and the mutant line was resistant to these effects of [E2]PI-PLC[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PI-PLC", "entity_1_idx": [[41, 47]], "entity_1_idx_in_text_with_entity_marker": [45, 51], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PI-PLC", "entity_2_idx": [[200, 206]], "entity_2_idx_in_text_with_entity_marker": [213, 219], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d129.s310_IEPA.d129.s310.p1", "text": "Intraperitoneal 6HDA, 100 mg/kg, as a single dose at 1800, increased plasma leptin approximately twofold after 18-20 h, increased IBAT (but not epididymal fat) leptin mRNA by two- to threefold, and decreased IBAT UCP-3 mRNA to 30-40% of control", "text_with_entity_marker": "Intraperitoneal 6HDA, 100 mg/kg, as a single dose at 1800, increased plasma [E1]leptin[/E1] approximately twofold after 18-20 h, increased IBAT (but not epididymal fat) leptin mRNA by two- to threefold, and decreased IBAT [E2]UCP-3[/E2] mRNA to 30-40% of control", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[76, 82]], "entity_1_idx_in_text_with_entity_marker": [80, 86], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[213, 218]], "entity_2_idx_in_text_with_entity_marker": [226, 231], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d138.s329_IEPA.d138.s329.p0", "text": "GPI-PLC was most pronouncedly stimulated by authentic human insulin compared to various insulin analogues and insulin-like growth factor I", "text_with_entity_marker": "[E1]GPI-PLC[/E1] was most pronouncedly stimulated by authentic human [E2]insulin[/E2] compared to various insulin analogues and insulin-like growth factor I", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "GPI-PLC", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[60, 67]], "entity_2_idx_in_text_with_entity_marker": [73, 80], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d140.s337_IEPA.d140.s337.p0", "text": "PKC was necessary in AVP- but not in LPA-induced activation of p70 S6K", "text_with_entity_marker": "[E1]PKC[/E1] was necessary in [E2]AVP[/E2]- but not in LPA-induced activation of p70 S6K", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PKC", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[21, 24]], "entity_2_idx_in_text_with_entity_marker": [34, 37], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d141.s338_IEPA.d141.s338.p0", "text": "Tolbutamide and diazoxide modulate phospholipase C-linked Ca(2+) signaling and insulin secretion in beta-cells", "text_with_entity_marker": "Tolbutamide and diazoxide modulate [E1]phospholipase C[/E1]-linked Ca(2+) signaling and [E2]insulin[/E2] secretion in beta-cells", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phospholipase C", "entity_1_idx": [[35, 50]], "entity_1_idx_in_text_with_entity_marker": [39, 54], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[79, 86]], "entity_2_idx_in_text_with_entity_marker": [92, 99], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d141.s340_IEPA.d141.s340.p0", "text": "Thus tolbutamide and diazoxide regulate both PLC-linked Ca(2+) signaling and insulin secretion from pancreatic beta-cells by modulating K(ATP) channels, thereby determining voltage-sensitive Ca(2+) influx", "text_with_entity_marker": "Thus tolbutamide and diazoxide regulate both [E1]PLC[/E1]-linked Ca(2+) signaling and [E2]insulin[/E2] secretion from pancreatic beta-cells by modulating K(ATP) channels, thereby determining voltage-sensitive Ca(2+) influx", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PLC", "entity_1_idx": [[45, 48]], "entity_1_idx_in_text_with_entity_marker": [49, 52], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[77, 84]], "entity_2_idx_in_text_with_entity_marker": [90, 97], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d145.s348_IEPA.d145.s348.p0", "text": "Aggregated A(beta) also decreased significantly the level of diacylglycerol, the product of PLC", "text_with_entity_marker": "Aggregated [E1]A(beta)[/E1] also decreased significantly the level of diacylglycerol, the product of [E2]PLC[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "A(beta)", "entity_1_idx": [[11, 18]], "entity_1_idx_in_text_with_entity_marker": [15, 22], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[92, 95]], "entity_2_idx_in_text_with_entity_marker": [105, 108], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d146.s351_IEPA.d146.s351.p0", "text": "Ca2+ signalling in rat vascular smooth muscle cells: a role for protein kinase C at physiological vasoconstrictor concentrations of vasopressin", "text_with_entity_marker": "Ca2+ signalling in rat vascular smooth muscle cells: a role for [E1]protein kinase C[/E1] at physiological vasoconstrictor concentrations of [E2]vasopressin[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "protein kinase C", "entity_1_idx": [[64, 80]], "entity_1_idx_in_text_with_entity_marker": [68, 84], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "vasopressin", "entity_2_idx": [[132, 143]], "entity_2_idx_in_text_with_entity_marker": [145, 156], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d146.s352_IEPA.d146.s352.p0", "text": "The protein kinase C (PKC) activator 4beta-phorbol 12-myristate 13-acetate (PMA, 100 pM to 200 nM), also stimulated Ca2+ spiking and this effect was additive with a submaximal concentration of AVP (50 pM)", "text_with_entity_marker": "The [E1]protein kinase C[/E1] (PKC) activator 4beta-phorbol 12-myristate 13-acetate (PMA, 100 pM to 200 nM), also stimulated Ca2+ spiking and this effect was additive with a submaximal concentration of [E2]AVP[/E2] (50 pM)", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "protein kinase C", "entity_1_idx": [[4, 20]], "entity_1_idx_in_text_with_entity_marker": [8, 24], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[193, 196]], "entity_2_idx_in_text_with_entity_marker": [206, 209], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d148.s361_IEPA.d148.s361.p2", "text": "CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain ucp genes and the leptin gene can be achieved, and suggest that adrenergic regulation of the leptin gene and of genes of the ucp family in adipose tissues is the result of complex interactions between the different beta-AR pathways", "text_with_entity_marker": "CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain [E1]ucp[/E1] genes and the leptin gene can be achieved, and suggest that adrenergic regulation of the leptin gene and of genes of the [E2]ucp[/E2] family in adipose tissues is the result of complex interactions between the different beta-AR pathways", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ucp", "entity_1_idx": [[90, 93]], "entity_1_idx_in_text_with_entity_marker": [94, 97], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "ucp", "entity_2_idx": [[215, 218]], "entity_2_idx_in_text_with_entity_marker": [228, 231], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d148.s361_IEPA.d148.s361.p4", "text": "CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain ucp genes and the leptin gene can be achieved, and suggest that adrenergic regulation of the leptin gene and of genes of the ucp family in adipose tissues is the result of complex interactions between the different beta-AR pathways", "text_with_entity_marker": "CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain ucp genes and the [E1]leptin[/E1] gene can be achieved, and suggest that adrenergic regulation of the leptin gene and of genes of the [E2]ucp[/E2] family in adipose tissues is the result of complex interactions between the different beta-AR pathways", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[108, 114]], "entity_1_idx_in_text_with_entity_marker": [112, 118], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "ucp", "entity_2_idx": [[215, 218]], "entity_2_idx_in_text_with_entity_marker": [228, 231], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d150.s363_IEPA.d150.s363.p0", "text": "Possible central nervous system (CNS) mechanisms could mediate these responses in that leptin receptors are located on hypothalamic neurons that coexpress neuropeptide-Y (NPY) or proopiomelanocortin (POMC) and both peptides that have been implicated as mediators of the CNS action of leptin.", "text_with_entity_marker": "Possible central nervous system (CNS) mechanisms could mediate these responses in that leptin receptors are located on hypothalamic neurons that coexpress [E1]neuropeptide-Y[/E1] (NPY) or proopiomelanocortin (POMC) and both peptides that have been implicated as mediators of the CNS action of [E2]leptin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "neuropeptide-Y", "entity_1_idx": [[155, 169]], "entity_1_idx_in_text_with_entity_marker": [159, 173], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[284, 290]], "entity_2_idx_in_text_with_entity_marker": [297, 303], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d152.s368_IEPA.d152.s368.p0", "text": "We examined for the first time in young men effects of intravenous injections of NPY (4x50 or 100 microg, n = 9 and 11, respectively, at 22.00, 23.00, 24.00 and 01.00 compared to saline) on the sleep electroencephalogram (EEG; recorded from 23.00 to 07.00) and nocturnal secretion of adrenocorticotrophic hormone (ACTH), cortisol, growth hormone (GH), prolactin and leptin", "text_with_entity_marker": "We examined for the first time in young men effects of intravenous injections of [E1]NPY[/E1] (4x50 or 100 microg, n = 9 and 11, respectively, at 22.00, 23.00, 24.00 and 01.00 compared to saline) on the sleep electroencephalogram (EEG; recorded from 23.00 to 07.00) and nocturnal secretion of adrenocorticotrophic hormone (ACTH), cortisol, growth hormone (GH), prolactin and [E2]leptin[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NPY", "entity_1_idx": [[81, 84]], "entity_1_idx_in_text_with_entity_marker": [85, 88], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[366, 372]], "entity_2_idx_in_text_with_entity_marker": [379, 385], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d155.s372_IEPA.d155.s372.p0", "text": "However, neither progesterone nor insulin increased phosphotyrosine on PLCgamma", "text_with_entity_marker": "However, neither progesterone nor [E1]insulin[/E1] increased phosphotyrosine on [E2]PLCgamma[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[34, 41]], "entity_1_idx_in_text_with_entity_marker": [38, 45], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLCgamma", "entity_2_idx": [[71, 79]], "entity_2_idx_in_text_with_entity_marker": [84, 92], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d159.s384_IEPA.d159.s384.p2", "text": "In conclusion, 1) UCP-2 messenger ribonucleic acid expression in sc adipose tissue is inversely related to adiposity and independently linked to local plasma leptin levels; and 2) UCP-2 expression is not acutely regulated by food intake, insulin, or fatty acids", "text_with_entity_marker": "In conclusion, 1) UCP-2 messenger ribonucleic acid expression in sc adipose tissue is inversely related to adiposity and independently linked to local plasma [E1]leptin[/E1] levels; and 2) [E2]UCP-2[/E2] expression is not acutely regulated by food intake, insulin, or fatty acids", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[158, 164]], "entity_1_idx_in_text_with_entity_marker": [162, 168], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-2", "entity_2_idx": [[180, 185]], "entity_2_idx_in_text_with_entity_marker": [193, 198], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s386_IEPA.d161.s386.p0", "text": "Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion", "text_with_entity_marker": "Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, [E1]leptin[/E1], [E2]uncoupling proteins 2[/E2] and 3, and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[93, 99]], "entity_1_idx_in_text_with_entity_marker": [97, 103], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling proteins 2", "entity_2_idx": [[101, 122]], "entity_2_idx_in_text_with_entity_marker": [114, 135], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d165.s400_IEPA.d165.s400.p0", "text": "At equimolar concentrations of leptin and NPY (10(-12) to 10(-6) M) the observed lipolytic activity is comparable to the basal lipolytic activity, except at a concentration of 10(-9) M where upon a significant increase in lipolysis is observed", "text_with_entity_marker": "At equimolar concentrations of [E1]leptin[/E1] and [E2]NPY[/E2] (10(-12) to 10(-6) M) the observed lipolytic activity is comparable to the basal lipolytic activity, except at a concentration of 10(-9) M where upon a significant increase in lipolysis is observed", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[31, 37]], "entity_1_idx_in_text_with_entity_marker": [35, 41], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[42, 45]], "entity_2_idx_in_text_with_entity_marker": [55, 58], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d168.s405_IEPA.d168.s405.p4", "text": "A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking leptin-induced hyperphagia, produced a marked decrease in the expression of muscle uncoupling protein-3 (UCP-3), whereas ICV infusion of leptin prevented such a decrease in UCP-3", "text_with_entity_marker": "A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking leptin-induced hyperphagia, produced a marked decrease in the expression of muscle [E1]uncoupling protein-3[/E1] (UCP-3), whereas ICV infusion of leptin prevented such a decrease in [E2]UCP-3[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "uncoupling protein-3", "entity_1_idx": [[169, 189]], "entity_1_idx_in_text_with_entity_marker": [173, 193], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[259, 264]], "entity_2_idx_in_text_with_entity_marker": [272, 277], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d168.s406_IEPA.d168.s406.p0", "text": "To further substantiate an involvement of thyroid hormones in the effect of leptin on muscle UCP-3 expression, hypothyroid rats were ICV infused with leptin or vehicle", "text_with_entity_marker": "To further substantiate an involvement of thyroid hormones in the effect of [E1]leptin[/E1] on muscle [E2]UCP-3[/E2] expression, hypothyroid rats were ICV infused with leptin or vehicle", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[76, 82]], "entity_1_idx_in_text_with_entity_marker": [80, 86], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[93, 98]], "entity_2_idx_in_text_with_entity_marker": [106, 111], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d168.s406_IEPA.d168.s406.p1", "text": "To further substantiate an involvement of thyroid hormones in the effect of leptin on muscle UCP-3 expression, hypothyroid rats were ICV infused with leptin or vehicle", "text_with_entity_marker": "To further substantiate an involvement of thyroid hormones in the effect of [E1]leptin[/E1] on muscle UCP-3 expression, hypothyroid rats were ICV infused with [E2]leptin[/E2] or vehicle", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[76, 82]], "entity_1_idx_in_text_with_entity_marker": [80, 86], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[150, 156]], "entity_2_idx_in_text_with_entity_marker": [163, 169], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d168.s407_IEPA.d168.s407.p0", "text": "It was observed that in hypothyroid rats, ICV leptin was unable to maintain muscle UCP-3 expression at values measured in ad libitum fed controls", "text_with_entity_marker": "It was observed that in hypothyroid rats, ICV [E1]leptin[/E1] was unable to maintain muscle [E2]UCP-3[/E2] expression at values measured in ad libitum fed controls", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[46, 52]], "entity_1_idx_in_text_with_entity_marker": [50, 56], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[83, 88]], "entity_2_idx_in_text_with_entity_marker": [96, 101], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d174.s422_IEPA.d174.s422.p3", "text": "Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration", "text_with_entity_marker": "Dietary intakes of flavonols, [E1]flavones[/E1] and [E2]isoflavones[/E2] by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "flavones", "entity_1_idx": [[30, 38]], "entity_1_idx_in_text_with_entity_marker": [34, 42], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "isoflavones", "entity_2_idx": [[43, 54]], "entity_2_idx_in_text_with_entity_marker": [56, 67], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d187.s448_IEPA.d187.s448.p0", "text": "In the present study, gibbestatin B (GNB) was isolated from Streptomyces sp. C-39 as an inhibitor of the GA-induced expression of alpha-amylase in barley and rice, with IC50 values of 125 and 70 microM, respectively.", "text_with_entity_marker": "In the present study, gibbestatin B (GNB) was isolated from Streptomyces sp. C-39 as an inhibitor of the [E1]GA[/E1]-induced expression of [E2]alpha-amylase[/E2] in barley and rice, with IC50 values of 125 and 70 microM, respectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "GA", "entity_1_idx": [[105, 107]], "entity_1_idx_in_text_with_entity_marker": [109, 111], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[130, 143]], "entity_2_idx_in_text_with_entity_marker": [143, 156], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d189.s453_IEPA.d189.s453.p1", "text": "These findings are consistent with increased leptin signaling to the NPY and POMC neurons in the ARC by physiological levels of circulating leptin during normal feeding", "text_with_entity_marker": "These findings are consistent with increased [E1]leptin[/E1] signaling to the NPY and POMC neurons in the ARC by physiological levels of circulating [E2]leptin[/E2] during normal feeding", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[45, 51]], "entity_1_idx_in_text_with_entity_marker": [49, 55], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[140, 146]], "entity_2_idx_in_text_with_entity_marker": [153, 159], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d191.s459_IEPA.d191.s459.p0", "text": "Similarly, central leptin treatment also had a greater effect in suppressing hypothalamic NPY mRNA expression in young (-23+/-4%) than in old (-8+/-4%) rats compared with their age-matched pair-fed treated rats", "text_with_entity_marker": "Similarly, central [E1]leptin[/E1] treatment also had a greater effect in suppressing hypothalamic [E2]NPY[/E2] mRNA expression in young (-23+/-4%) than in old (-8+/-4%) rats compared with their age-matched pair-fed treated rats", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[19, 25]], "entity_1_idx_in_text_with_entity_marker": [23, 29], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[90, 93]], "entity_2_idx_in_text_with_entity_marker": [103, 106], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d192.s460_IEPA.d192.s460.p0", "text": "Compared with the wild type, GA induction of alpha-amylase activity in aleurone cells of d1 was greatly reduced", "text_with_entity_marker": "Compared with the wild type, [E1]GA[/E1] induction of [E2]alpha-amylase[/E2] activity in aleurone cells of d1 was greatly reduced", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "GA", "entity_1_idx": [[29, 31]], "entity_1_idx_in_text_with_entity_marker": [33, 35], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[45, 58]], "entity_2_idx_in_text_with_entity_marker": [58, 71], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d192.s461_IEPA.d192.s461.p2", "text": "Relative to the wild type, the GA(3)-treated aleurone layer of d1 had lower expression of Ramy1A, which encodes alpha-amylase, and OsGAMYB, which encodes a GA-inducible transcriptional factor, and no increase in expression of Ca(2 +)-ATPase", "text_with_entity_marker": "Relative to the wild type, the GA(3)-treated aleurone layer of d1 had lower expression of Ramy1A, which encodes [E1]alpha-amylase[/E1], and OsGAMYB, which encodes a [E2]GA[/E2]-inducible transcriptional factor, and no increase in expression of Ca(2 +)-ATPase", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-amylase", "entity_1_idx": [[112, 125]], "entity_1_idx_in_text_with_entity_marker": [116, 129], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "GA", "entity_2_idx": [[156, 158]], "entity_2_idx_in_text_with_entity_marker": [169, 171], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d192.s463_IEPA.d192.s463.p0", "text": "All these results suggest that d1 affects a part of the GA-signaling pathway, namely the induction of alpha-amylase in the aleurone layer and internode elongation", "text_with_entity_marker": "All these results suggest that d1 affects a part of the [E1]GA[/E1]-signaling pathway, namely the induction of [E2]alpha-amylase[/E2] in the aleurone layer and internode elongation", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "GA", "entity_1_idx": [[56, 58]], "entity_1_idx_in_text_with_entity_marker": [60, 62], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[102, 115]], "entity_2_idx_in_text_with_entity_marker": [115, 128], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d195.s471_IEPA.d195.s471.p0", "text": "We measured concentrations of NPY and CRH in specific hypothalamic regions [i.e., arcuate nucleus (ARC), paraventricular nucleus (PVN), ventromedial nucleus and dorsomedial nucleus] of 7- to 8-wk-old lean and ob/ob mice at 1 or 3 h after intracerebroventricular leptin administration", "text_with_entity_marker": "We measured concentrations of [E1]NPY[/E1] and CRH in specific hypothalamic regions [i.e., arcuate nucleus (ARC), paraventricular nucleus (PVN), ventromedial nucleus and dorsomedial nucleus] of 7- to 8-wk-old lean and ob/ob mice at 1 or 3 h after intracerebroventricular [E2]leptin[/E2] administration", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NPY", "entity_1_idx": [[30, 33]], "entity_1_idx_in_text_with_entity_marker": [34, 37], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[262, 268]], "entity_2_idx_in_text_with_entity_marker": [275, 281], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d197.s478_IEPA.d197.s478.p0", "text": "Bovine prion protein as a modulator of protein kinase CK2", "text_with_entity_marker": "[E1]Bovine prion protein[/E1] as a modulator of [E2]protein kinase CK2[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Bovine prion protein", "entity_1_idx": [[0, 20]], "entity_1_idx_in_text_with_entity_marker": [4, 24], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase CK2", "entity_2_idx": [[39, 57]], "entity_2_idx_in_text_with_entity_marker": [52, 70], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d197.s480_IEPA.d197.s480.p0", "text": "We also show that bPrP counteracts the inhibition of calmodulin phosphorylation promoted by the regulatory beta subunits of CK2", "text_with_entity_marker": "We also show that [E1]bPrP[/E1] counteracts the inhibition of calmodulin phosphorylation promoted by the regulatory beta subunits of [E2]CK2[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "bPrP", "entity_1_idx": [[18, 22]], "entity_1_idx_in_text_with_entity_marker": [22, 26], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "CK2", "entity_2_idx": [[124, 127]], "entity_2_idx_in_text_with_entity_marker": [137, 140], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d199.s485_IEPA.d199.s485.p1", "text": "Our results indicate that glucose represses gibberellin signalling late along this hormone transduction pathway, downstream of transcription of the gibberellin-modulated transcriptional activator (GAMYB) needed for alpha-amylase induction", "text_with_entity_marker": "Our results indicate that glucose represses [E1]gibberellin[/E1] signalling late along this hormone transduction pathway, downstream of transcription of the gibberellin-modulated transcriptional activator (GAMYB) needed for [E2]alpha-amylase[/E2] induction", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gibberellin", "entity_1_idx": [[44, 55]], "entity_1_idx_in_text_with_entity_marker": [48, 59], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[215, 228]], "entity_2_idx_in_text_with_entity_marker": [228, 241], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
